Po-sung Chu

チョハクショウ | Po-sung Chu

Affiliation and department：
Job title：専任講師

Research field (2)： Immunology , Gastroenterology

Research keywords (5)： autoimmune hepatitis , Liver failure , Viral hepatitis , Immunology of liver diseases , Liver fibrosis

Research theme for competitive and other funds (4)：

2022 - 2025 Analyses and applications of novel anti-fibrotic treatment for cirrhosis via the gut-liver axis
2019 - 2021 Mechanism of the Plasticity of Innate Immunity during Metabolic Re-compensation in Liver Cirrhosis
2016 - 2019 Role of gut microbiota in the pathogenesis of primly sclerosing cholangitis
2016 - 2019 肝線維化を抑制するRestorative Macrophageの誘導機序の解明

Papers (51)：

Masataka Ichikawa, Haruka Okada, Nobuhiro Nakamoto, Nobuhito Taniki, Po-Sung Chu, Takanori Kanai. The gut-liver axis in hepatobiliary diseases. Inflammation and regeneration. 2024. 44. 1. 2-2
Sota Fujimori, Po-Sung Chu, Toshiaki Teratani, Yosuke Harada, Takahiro Suzuki, Takeru Amiya, Nobuhito Taniki, Ryosuke Kasuga, Yohei Mikami, Yuzo Koda, et al. IL-15-producing splenic B cells play pathogenic roles in the development of autoimmune hepatitis. JHEP Reports. 2023. 5. 7. 100757-100757
Ishigaki Sho, Yasushi Kondo, Yuichiro Ota, Po-Sung Chu, Hironari Hanaoka, Tsutomu Takeuchi, Yuko Kaneko. Successful treatment of refractory enteritis and arthritis with combination of TNF and IL-6 inhibition in patients with ulcerative colitis. Modern Rheumatology Case Reports. 2023
Masataka Ichikawa, Nobuhiro Nakamoto, Sharon Kredo-Russo, Eyal Weinstock, Iddo Nadav Weiner, Efrat Khabra, Noa Ben-Ishai, Dana Inbar, Noga Kowalsman, Ron Mordoch, et al. Bacteriophage therapy against pathological Klebsiella pneumoniae ameliorates the course of primary sclerosing cholangitis. Nature Communications. 2023. 14. 1. 3261-3261
柏松褚, 伸宏中本, 隆典金井. 急性肝不全の病態解明up to date. 2023

ｍore...

MISC (52)：

Ryosuke Kasuga, Po-Sung Chu, Nobuhito Taniki, Nobuhiro Nakamoto, Takanori Kanai. SERUM ALBUMIN LEVELS IMPROVE TRANSPLANT-FREE SURVIVAL PREDICTING PERFORMANCE OF CLIF-C ACLF SCORES IN CIRRHOTIC PATIENTS SUFFERED FROM AD/ACLF BEYOND 90 DAYS. HEPATOLOGY. 2022. 76. S914-S915
Nobuhito Taniki, Ryosuke Kasuga, Po-Sung Chu, Akihiro Yamaguchi, Hitomi Hoshi, Keisuke Ojiro, Fumihiko Kaneko, Nobuhiro Nakamoto, Takanori Kanai. PRIOR HISTORY OF LOCOREGIONAL THERAPY ASSOCIATES WITH TACE REFRACTORINESS IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA. HEPATOLOGY. 2022. 76. S1403-S1403
Po-Sung Chu, Fumie Noguchi, Yasushi Hasegawa, Nobuhito Taniki, Rei Morikawa, Nobuhiro Nakamoto, Takanori Kanai. PREDICTION OF IMMUNOSUPPRESSION RESPONSIVENESS, SURVIVAL OUTCOME AND SEVERE INFECTIONS IN CORTICOSTEROIDS-TREATED PATIENTS WITH SEVERE ACUTE-ONSET AUTOIMMUNE HEPATITIS. HEPATOLOGY. 2021. 74. 774A-775A
Yuzo Koda, Toshiaki Teratani, Po-Sung Chu, Nobuhito Taniki, Takanori Kanai, Nobuhiro Nakamoto. ROLES OF CD8+TISSUE-RESIDENT MEMORY T CELLS IN LIVER FIBROSIS RESOLUTION. HEPATOLOGY. 2021. 74. 829A-830A
堀江義則, 谷木信仁, Chu Po-sung, 中本伸宏, 金井隆典. Effect of physician-prescribed nalmefene on alcohol intake reduction in patients with alcohol-related liver disease. 肝臓. 2021. 62. 10

ｍore...

Lectures and oral presentations (17)：

「90日以内の再急性非代償化」が非代償性肝硬変患者の予後不良を予測する: 日本ACLF診断基準(案)の検証および治療戦略の構築に向けて
(日本肝臓学会総会 2019)
A shorter period of a subsequent episode of acute decompensation of cirrhosis predicts worse outcome: A single-center experience
(EASL ILC 2019 2019)
アルコール性・非アルコール性脂肪性肝硬変における慢性肝不全急性増悪の臨床病態の異同
(日本消化器病学会総会 (2018 Tokyo) 2018)
Modification of the MELD score with serological fibrosis markers that reflect extracellular matrix remodeling improves prediction of outcome in non-acetaminophen-associated acute liver failure
(AASLD2017 (Washinton DC) 2017)
当院における肝移植後C型肝炎再発に対するIFN-free DAA治療経験:治療後早期肝合成能の改善からみた治療導入のタイミング
(JDDW2017 2017)

ｍore...

Education (3)：

2009 - 2013 Graduate School of Keio University
1997 - 2004 National Taiwan University School of Medicine Department of Medicine
1994 - 1997 Taipei Municiple Jianguo Senior High School

Professional career (2)：

博士(医学) (慶應義塾大学)
MD (National Taiwan University)

Work history (3)：

2020/08 - 現在慶應義塾大学医学部内科学(消化器) 専任講師
2019/06 - 現在 Department of Internal Medicine (Gastroenterology and Hepatology), School of Medicine, Keio University
2014/06 - 現在 Keio University Department of Gastroenterology and Hepatology, Internal Medicine, School of Medicine Assistant Professor

Awards (6)：

2022/01 - 慶應義塾大学医学部内科学教室症例報告最優秀賞(指導医)
2020/05 - 慶應義塾大学医学部内科学教室症例報告最優秀賞(指導医)
2018/11 - JDDW2018 若手奨励賞
2018/04 - 日本内科学会優秀教官賞
2014/10 - 日本肝臓学会 Bristol-Myres Award

Show all

Association Membership(s) (4)：

JAPAN GASTROENTEROLOGICAL ENDOSCOPY SOCIETY , THE JAPAN SOCIETY OF HEPATOLOGY , JAPANESE SOCIETY OF GASTROENTEROLOGY , THE JAPANESE SOCIETY OF INTERNAL MEDICINE

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page